Effect of calfhood vaccination on transmission of bovine viral diarrhea virus under typical drylot dairy conditions

Mark Thurmond, Claudia A. Muñoz-Zanzi, Sharon K. Hietala

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Objective - To estimate transmission of bovine viral diarrhea virus (BVDV) and crude morbidity and mortality ratios in BVDV-vaccinated and unvaccinated dairy heifer calves managed under typical dairy drylot conditions. Design - Randomized clinical trial. Animals - 106 female Holstein calves. Procedure - Seroconversion rates for BVDV types I and II and proportional morbidity and mortality ratios were compared between calves given a killed BVDV type-I vaccine at 15 days of age and a modified-live BVDV type-I vaccine at 40 to 45 days of age (n = 53) and calves given no BVDV vaccines (53). Sera were collected at 45-day intervals as calves moved from individual hutches to corrals holding increasingly larger numbers of calves. Seroconversion was used as evidence of exposure to BVDV. Results - Crude proportional morbidity (0.16) and mortality (0.17) ratios for control calves did not differ significantly from those of vaccinated calves (0.28 and 0.12, respectively). The proportion of control calves that seroconverted to BVDV type I through 9 months of age (0.629) was significantly higher than that of vaccinated calves that seroconverted, unrelated to vaccination, during the same period (0.536). Estimated overall protective effect of vaccination against BVDV type I through 4 to 9 months of age was 48%. The proportion of control calves that seroconverted to BVDV type II (0.356) was not different from that of vaccinated calves (0.470). Conclusions and Clinical Relevance - Findings suggest that calfhood vaccination may be an appropriate strategy to help reduce short-term transmission of some but not necessarily all strains of BVDV.

Original languageEnglish (US)
Pages (from-to)968-975
Number of pages8
JournalJournal of the American Veterinary Medical Association
Volume219
Issue number7
DOIs
StatePublished - Oct 1 2001

Fingerprint

Bovine Viral Diarrhea Viruses
Bovine viral diarrhea virus
dairies
Vaccination
vaccination
calves
morbidity
Vaccines
Morbidity
seroconversion
vaccines
Mortality
dairy heifers
randomized clinical trials
protective effect
Randomized Controlled Trials

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Effect of calfhood vaccination on transmission of bovine viral diarrhea virus under typical drylot dairy conditions. / Thurmond, Mark; Muñoz-Zanzi, Claudia A.; Hietala, Sharon K.

In: Journal of the American Veterinary Medical Association, Vol. 219, No. 7, 01.10.2001, p. 968-975.

Research output: Contribution to journalArticle

@article{6fae84693ef74a12bff3d1850ff7d412,
title = "Effect of calfhood vaccination on transmission of bovine viral diarrhea virus under typical drylot dairy conditions",
abstract = "Objective - To estimate transmission of bovine viral diarrhea virus (BVDV) and crude morbidity and mortality ratios in BVDV-vaccinated and unvaccinated dairy heifer calves managed under typical dairy drylot conditions. Design - Randomized clinical trial. Animals - 106 female Holstein calves. Procedure - Seroconversion rates for BVDV types I and II and proportional morbidity and mortality ratios were compared between calves given a killed BVDV type-I vaccine at 15 days of age and a modified-live BVDV type-I vaccine at 40 to 45 days of age (n = 53) and calves given no BVDV vaccines (53). Sera were collected at 45-day intervals as calves moved from individual hutches to corrals holding increasingly larger numbers of calves. Seroconversion was used as evidence of exposure to BVDV. Results - Crude proportional morbidity (0.16) and mortality (0.17) ratios for control calves did not differ significantly from those of vaccinated calves (0.28 and 0.12, respectively). The proportion of control calves that seroconverted to BVDV type I through 9 months of age (0.629) was significantly higher than that of vaccinated calves that seroconverted, unrelated to vaccination, during the same period (0.536). Estimated overall protective effect of vaccination against BVDV type I through 4 to 9 months of age was 48{\%}. The proportion of control calves that seroconverted to BVDV type II (0.356) was not different from that of vaccinated calves (0.470). Conclusions and Clinical Relevance - Findings suggest that calfhood vaccination may be an appropriate strategy to help reduce short-term transmission of some but not necessarily all strains of BVDV.",
author = "Mark Thurmond and Mu{\~n}oz-Zanzi, {Claudia A.} and Hietala, {Sharon K.}",
year = "2001",
month = "10",
day = "1",
doi = "10.2460/javma.2001.219.968",
language = "English (US)",
volume = "219",
pages = "968--975",
journal = "Journal of the American Veterinary Medical Association",
issn = "0003-1488",
publisher = "American Veterinary Medical Association",
number = "7",

}

TY - JOUR

T1 - Effect of calfhood vaccination on transmission of bovine viral diarrhea virus under typical drylot dairy conditions

AU - Thurmond, Mark

AU - Muñoz-Zanzi, Claudia A.

AU - Hietala, Sharon K.

PY - 2001/10/1

Y1 - 2001/10/1

N2 - Objective - To estimate transmission of bovine viral diarrhea virus (BVDV) and crude morbidity and mortality ratios in BVDV-vaccinated and unvaccinated dairy heifer calves managed under typical dairy drylot conditions. Design - Randomized clinical trial. Animals - 106 female Holstein calves. Procedure - Seroconversion rates for BVDV types I and II and proportional morbidity and mortality ratios were compared between calves given a killed BVDV type-I vaccine at 15 days of age and a modified-live BVDV type-I vaccine at 40 to 45 days of age (n = 53) and calves given no BVDV vaccines (53). Sera were collected at 45-day intervals as calves moved from individual hutches to corrals holding increasingly larger numbers of calves. Seroconversion was used as evidence of exposure to BVDV. Results - Crude proportional morbidity (0.16) and mortality (0.17) ratios for control calves did not differ significantly from those of vaccinated calves (0.28 and 0.12, respectively). The proportion of control calves that seroconverted to BVDV type I through 9 months of age (0.629) was significantly higher than that of vaccinated calves that seroconverted, unrelated to vaccination, during the same period (0.536). Estimated overall protective effect of vaccination against BVDV type I through 4 to 9 months of age was 48%. The proportion of control calves that seroconverted to BVDV type II (0.356) was not different from that of vaccinated calves (0.470). Conclusions and Clinical Relevance - Findings suggest that calfhood vaccination may be an appropriate strategy to help reduce short-term transmission of some but not necessarily all strains of BVDV.

AB - Objective - To estimate transmission of bovine viral diarrhea virus (BVDV) and crude morbidity and mortality ratios in BVDV-vaccinated and unvaccinated dairy heifer calves managed under typical dairy drylot conditions. Design - Randomized clinical trial. Animals - 106 female Holstein calves. Procedure - Seroconversion rates for BVDV types I and II and proportional morbidity and mortality ratios were compared between calves given a killed BVDV type-I vaccine at 15 days of age and a modified-live BVDV type-I vaccine at 40 to 45 days of age (n = 53) and calves given no BVDV vaccines (53). Sera were collected at 45-day intervals as calves moved from individual hutches to corrals holding increasingly larger numbers of calves. Seroconversion was used as evidence of exposure to BVDV. Results - Crude proportional morbidity (0.16) and mortality (0.17) ratios for control calves did not differ significantly from those of vaccinated calves (0.28 and 0.12, respectively). The proportion of control calves that seroconverted to BVDV type I through 9 months of age (0.629) was significantly higher than that of vaccinated calves that seroconverted, unrelated to vaccination, during the same period (0.536). Estimated overall protective effect of vaccination against BVDV type I through 4 to 9 months of age was 48%. The proportion of control calves that seroconverted to BVDV type II (0.356) was not different from that of vaccinated calves (0.470). Conclusions and Clinical Relevance - Findings suggest that calfhood vaccination may be an appropriate strategy to help reduce short-term transmission of some but not necessarily all strains of BVDV.

UR - http://www.scopus.com/inward/record.url?scp=0035487061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035487061&partnerID=8YFLogxK

U2 - 10.2460/javma.2001.219.968

DO - 10.2460/javma.2001.219.968

M3 - Article

C2 - 11601795

AN - SCOPUS:0035487061

VL - 219

SP - 968

EP - 975

JO - Journal of the American Veterinary Medical Association

JF - Journal of the American Veterinary Medical Association

SN - 0003-1488

IS - 7

ER -